Five Prime Therapeutics to Announce Second Quarter 2019 Financial Results and Host Conference Call
July 31 2019 - 09:16PM
Business Wire
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage
biotechnology company focused on discovering and developing
innovative immuno-oncology protein therapeutics, will report its
second quarter 2019 financial results on Wednesday, August 7, 2019
after the U.S. financial markets close. Five Prime will also host a
conference call and live audio webcast on August 7th at 4:30 p.m.
(ET) / 1:30 p.m. (PT) to discuss the company's financial results
and provide a general business update.
The live audio webcast may be accessed through the "Events &
Presentations" page in the "Investors" section of the company's
website at www.fiveprime.com. Alternatively, participants may dial
(877) 878-2269 (domestic) or (253) 237-1188 (international) and
refer to conference ID: 3575436.
The archived conference call will be available on Five Prime's
website beginning approximately two hours after the event and will
be archived and available for replay for at least 30 days after the
event.
About Five Prime Therapeutics
Five Prime Therapeutics, Inc. discovers and develops innovative
protein therapeutics to improve the lives of patients with serious
diseases. Five Prime’s product candidates have innovative
mechanisms of action and address patient populations in need of
better therapies. The company focuses on researching and developing
immuno-oncology and targeted cancer therapies paired with companion
diagnostics to identify patients who are most likely to benefit
from treatment with Five Prime’s product candidates. Five Prime has
entered into strategic collaborations with leading global
pharmaceutical companies and has promising product candidates in
clinical and preclinical development. For more information, please
visit www.fiveprime.com or follow us on LinkedIn, Twitter and
Facebook.
Source: Five Prime Therapeutics, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190731006122/en/
Media and Investor Contact Martin Forrest VP, Investor
Relations & Corporate Communications Five Prime Therapeutics,
Inc. 415-365-5625 martin.forrest@fiveprime.com
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Mar 2023 to Mar 2024